Intuitive Surgical, Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Intuitive Surgical, Inc. stock analysis ISRG overview
Somewhat Bullish +35

Intuitive Surgical (ISRG) Stock Could Be 23.6% Undervalued After Q1 da Vinci 5 Demand - simplywall.st

📈 Q1 2026 results show 431 da Vinci systems placed, a 17% year-over-year increase driven by da Vinci 5 upgrades.

💰 Analysts calculate a fair value of $532.46, implying the stock is 23.6% undervalued relative to the recent close of $406.78.

📉 Share price momentum has softened with a 27.62% decline year-to-date despite positive operational metrics.

🔮 Valuation model projects 12% annual revenue growth and expanding profit margins reaching 30% over the next five years.

⚖️ Current P/E ratio of 48.4x is significantly higher than the industry average of 24.4x and fair estimate of 31.3x.

🛡️ The company maintains a strong balance sheet with recurring revenue streams from spare parts and software licenses.

⚠️ Key risks include potential slowdowns in procedure volumes or pricing pressure from competing robotic systems.

Bullish Signals
  • Q1 2026 data reveals a 17% year-over-year increase in da Vinci system placements, totaling 431 units.
  • The company is experiencing an upgrade cycle to the da Vinci 5 model alongside increased leasing activity.
  • Analyst fair value calculations suggest the stock is undervalued by 23.6%, with a target price of $532.46.
  • Projected revenue growth of 12% annually is supported by recurring revenue from spare parts and software licenses.
  • Profit margins are expected to expand from 28.6% to 30% as high-margin service revenue grows.
Risk Factors
  • The stock has declined 27.62% year-to-date, indicating significant short-term share price weakness.
  • Current P/E ratio of 48.4x is nearly double the wider US Medical Equipment industry average of 24.4x.
  • Valuation risk exists if procedure volumes slow down or instrument usage decreases in future quarters.
  • New competing robotic systems could pressure pricing power and hinder installed base growth.
Full Analysis
Intuitive Surgical (ISRG) is highlighted as potentially undervalued following Q1 2026 data showing strong demand for its da Vinci 5 robotic surgery systems. The company placed 431 units in the quarter, representing a 17% year-over-year increase, driven by an upgrade cycle and higher leasing activity among hospitals. Despite this operational strength, ISRG's share price has softened significantly, dropping 27.62% year-to-date. However, analysts using Simply Wall St methodology calculate a fair value of $532.46 compared to the recent closing price of $406.78, suggesting the stock is approximately 23.6% undervalued based on projected revenue growth and margin expansion. The valuation model assumes annual revenue growth of 12%, profit margins expanding to 30%, and a future P/E ratio of 50x. While the analysis points to an opportunity, it acknowledges risks such as slowing procedure volumes or competitive pressure from new systems that could challenge these optimistic assumptions.